Jeffrey H. Samet, MD, MA, MPH
Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
General Internal Medicine

MD, Baylor College of Medicine
MPH, Boston University
MA, Brandeis University
BA, Brandeis University



My research has focused on alcohol and drug use, HIV infection and primary medical care with the following specific projects: linkage of alcohol and drug use treatment and primary medical care; addressing alcohol and drug use issues in the primary care setting; the impact of alcohol and drug use in HIV-infected persons; HIV prevention and treatment in Russian substance users; and establishing medical care for HIV-infected persons.

Diversity, Equity, Inclusion and Accessibility

I have worked at Boston City Hospital and Boston Medical Center for the vast majority of the past 4 decades in large measure as a consequence of my desire to serve a safety net community. My focus clinically and from a research perspective has been on patients seen in this setting in primary care, many of whom have substance use disorders and some with HIV infection. Minority populations are disproportionately impacted by these medical conditions.

It is valuable to leverage the power of diverse backgrounds, experiences, and perspectives in solving complex problems. To achieve this goal, support for individuals from underrepresented groups is needed and I have sought to do this in my extensive mentoring efforts. Highlights of this work has been my support as the primary mentor for two black faculty on their NIH career development awards (K awards). Other work advancing these training goal occurs in my support and work with the CRIT (Chief Resident Immersion Training) Program, RAMS (Research in Addiction Medicine Scholars) Program and the Inclusion Diversity & Equity In Addiction medicine, Addiction health professions, and Addiction research (IDEAAA) program.

As Section Chief of General Internal Medicine for nearly 20 years (2002 – 2021), we recruited and supported the largest number of faculty from underrepresented groups in the Department of Medicine.

Professor
Boston University School of Public Health
Community Health Sciences


Member
Boston University
Evans Center for Interdisciplinary Biomedical Research


Faculty
Boston University Chobanian & Avedisian School of Medicine
Medicine
Clinical Addiction Research and Education Unit



Kaku So-Armah ZINC Diversity Supplement-Vanderbilt
04/30/2016 - 07/31/2016 (PI)
Vanderbilt University Medical Center


Kaku So-Armah ZINC Diversity Supplement: Vanderbilt
02/01/2015 - 04/29/2016 (PI)
Vanderbilt University Medical Center


Faculty Development Program Grant
09/30/1998 - 03/29/2002 (PI)
HHS/SAMHSA/Center for Substance Abuse Prevention
5 T26 SP08355 03


Clinical Addiction Research and Education (CARE) Program Renewal
07/01/2022 - 05/31/2027 (PI)
National Institute on Drug Abuse/NIH/DHHS
2R25DA013582-21

The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center
09/10/2021 - 08/31/2026 (PI)
National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS
1P01AA029541-01

Pre notification Advancing Clinical Research Training within Addiction Residency Programs
04/01/2024 - 03/31/2025 (PI)
National Institute on Drug Abuse/NIH/DHHS

MassHEAL - Reducing overdose deaths by 40% (2019-2023) (Administrative Supplement)
09/15/2023 - 03/31/2025 (PI)
National Institute on Drug Abuse/NIH/DHHS

MassHEAL - Reducing overdose deaths by 40% (2019-2023)
04/01/2021 - 03/31/2025 (PI)
National Institute on Drug Abuse/NIH/DHHS
3UM1DA049412-04S2

ID -MassHEAL - Reducing overdose deaths by 40% (2019-2023)
04/17/2019 - 03/31/2025 (PI)
National Institute on Drug Abuse/NIH/DHHS
3UM1DA049412-04S2

Subcontracts- MassHEAL - Reducing overdose deaths by 40% (2019-2023)
04/17/2019 - 03/31/2025 (PI)
National Institute on Drug Abuse/NIH/DHHS
3UM1DA049412-04S2

Community Subcontracts- MassHEAL - Reducing overdose deaths by 40% (2019-2023)
04/17/2019 - 03/31/2025 (PI)
National Institute on Drug Abuse/NIH/DHHS
3UM1DA049412-04S2

MassHEAL - Reducing overdose deaths by 40% (2019-2023)
04/17/2019 - 03/31/2025 (PI)
National Institute on Drug Abuse/NIH/DHHS
3UM1DA049412-04S2

The National Drug Abuse Clinical Trials Network: New England Consortium Node (Central CTN Activities)
03/01/2022 - 02/28/2025 (PI)
Yale University School of Medicine National Institute o

Showing 10 of 79 results. Show All Results

Title


Yr Title Project-Sub Proj Pubs
2024 Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention" 5R01AA030460-03
2024 Advancing Clinical Research Training within Addiction Residency Programs 2R25DA033211-11A1
2024 Clinical Addiction Research and Education (CARE) Program 5R25DA013582-23
2023 MassHEAL - Reducing overdose deaths by 40% (2019-2023) 3UM1DA049412-04S2
2023 Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention" 5R01AA030460-02
2023 The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center 3P01AA029541-02S1
2023 The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center 5P01AA029541-03
2023 The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center 3P01AA029541-03S1
2023 Administrative Core 5P01AA029541-03-5222
2023 Clinical Addiction Research and Education (CARE) Program 5R25DA013582-22
Showing 10 of 194 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Kimmel SD, Walley AY, White LF, Yan S, Grella C, Majeski A, Stein MD, Bettano A, Bernson D, Drainoni ML, Samet JH, Larochelle MR. Medication for Opioid Use Disorder After Serious Injection-Related Infections in Massachusetts. JAMA Netw Open. 2024 Jul 01; 7(7):e2421740.View Related Profiles. PMID: 39046742; PMCID: PMC11270137; DOI: 10.1001/jamanetworkopen.2024.21740;
     
  2. Samet JH, El-Bassel N, Winhusen TJ, Jackson RD, Oga EA, Chandler RK, Villani J, Freisthler B, Adams J, Aldridge A, Angerame A, Babineau DC, Bagley SM, Baker TJ, Balvanz P, Barbosa C, Barocas J, Battaglia TA, Beard DD, Beers D, Blevins D, Bove N, Bridden C, Brown JL, Bush HM, Bush JL, Caldwell R, Calver K, Calvert D, Campbell ANC, Carpenter J, Caspar R, Chassler D, Chaya J, Cheng DM, Cunningham CO, Dasgupta A, David JL, Davis A, Dean T, Drainoni ML, Eggleston B, Fanucchi LC, Feaster DJ, Fernandez S, Figueroa W, Freedman DA, Freeman PR, Freiermuth CE, Friedlander E, Gelberg KH, Gibson EB, Gilbert L, Glasgow L, Goddard-Eckrich DA, Gomori S, Gruss DE, Gulley J, Gutnick D, Hall ME, Harger Dykes N, Hargrove SL, Harlow K, Harris A, Harris D, Helme DW, Holloway J, Hotchkiss J, Huang T, Huerta TR, Hunt T, Hyder A, Ingram VL, Ingram T, Kauffman E, Kimball JL, Kinnard EN, Knott C, Knudsen HK, Konstan MW, Kosakowski S, Larochelle MR, Leaver HM, LeBaron PA, Lefebvre RC, Levin FR, Lewis N, Lewis N, Lofwall MR, Lounsbury DW, Luster JE, Lyons MS, Mack A, Marks KR, Marquesano S, Mauk R, McAlearney AS, McConnell K, McGladrey ML, McMullan J, Miles J, Munoz Lopez R, Nelson A, Neufeld JL, Newman L, Nguyen TQ, Nunes EV, Oller DA, Oser CB, Oyler DR, Pagnano S, Parran TV, Powell J, Powers K, Ralston W, Ramsey K, Rapkin BD, Reynolds JG, Roberts MF, Robertson W, Rock P, Rodgers E, Rodriguez S, Rudorf M, Ryan S, Salsberry P, Salvage M, Sabounchi N, Saucier M, Savitzky C, Schackman B, Schady E, Seiber EE, Shadwick A, Shoben A, Slater MD, Slavova S, Speer D, Sprunger J, Starbird LE, Staton M, Stein MD, Stevens-Watkins DJ, Stopka TJ, Sullivan A, Surratt HL, Sword Cruz R, Talbert JC, Taylor JL, Thompson KL, Vandergrift N, Vickers-Smith RA, Vietze DJ, Walker DM, Walley AY, Walters ST, Weiss R, Westgate PM, Wu E, Young AM, Zarkin GA, Walsh SL. Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths. N Engl J Med. 2024 Jun 16.View Related Profiles. PMID: 38884347
     
  3. Bobb JF, Idu AE, Qiu H, Yu O, Boudreau DM, Wartko PD, Matthews AG, McCormack J, Lee AK, Campbell CI, Saxon AJ, Liu DS, Altschuler A, Samet JH, Northrup TF, Braciszewski JM, Murphy MT, Arnsten JH, Cunningham CO, Horigian VE, Szapocznik J, Glass JE, Caldeiro RM, Tsui JI, Burganowski RP, Weinstein ZM, Murphy SM, Hyun N, Bradley KA. Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial. Drug Alcohol Depend. 2024 Aug 01; 261:111350.View Related Profiles. PMID: 38875880; PMCID: PMC11281026; DOI: 10.1016/j.drugalcdep.2024.111350;
     
  4. Harris MT, Weinberger E, O'Brien C, Althoff M, Paltrow-Krulwich S, Taylor JL, Judge A, Samet JH, Walley AY, Gunn CM. PrEP facilitators and barriers in substance use bridge clinics for women who engage in sex work and who use drugs. Addict Sci Clin Pract. 2024 Jun 03; 19(1):47.View Related Profiles. PMID: 38831359; PMCID: PMC11145858; DOI: 10.1186/s13722-024-00476-4;
     
  5. Idrisov B, Van Draanen J, Lodi S, Lunze K, Kimmel SD, Quinn EK, Truong V, Blokhina E, Gnatienko N, Krupitsky E, Samet JH, Williams EC. Socioeconomic Status and CD4 Count Among People with HIV Who Inject Drugs in St. Petersburg, Russia. AIDS Behav. 2024 Jul; 28(7):2239-2246.View Related Profiles. PMID: 38658481; DOI: 10.1007/s10461-024-04316-z;
     
  6. Glasgow L, Douglas C, Sprunger JG, Campbell ANC, Chandler R, Dasgupta A, Holloway J, Marks KR, Roberts SM, Martinez LS, Thompson K, Weiss RD, Aldridge A, Asman K, Barbosa C, Blevins D, Chassler D, Cogan L, Fanucchi L, Hall ME, Hunt T, Jadovich E, Levin FR, Lincourt P, Lofwall MR, Loukas V, McAlearney AS, Nunes E, Oga E, Oller D, Rudorf M, Sullivan AM, Talbert J, Taylor A, Teater J, Vandergrift N, Woodlock K, Zarkin GA, Freisthler B, Samet JH, Walsh SL, El-Bassel N. Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trial. Drug Alcohol Depend. 2024 Jun 01; 259:111286.View Related Profiles. PMID: 38626553; PMCID: PMC11111326; DOI: 10.1016/j.drugalcdep.2024.111286;
     
  7. Kim TW, Bertholet N, Magane KM, Lloyd-Travaglini C, Winter MR, Samet JH, Erlandson KM, Stein MD, Bryant KJ, Saitz R, Heeren TC. Alcohol Consumption and Illicit Drug Use: Associations With Fall, Fracture, and Acute Health Care Utilization Among People With HIV Infection. J Acquir Immune Defic Syndr. 2024 Apr 01; 95(4):391-398.View Related Profiles. PMID: 38133581; PMCID: PMC10922845; DOI: 10.1097/QAI.0000000000003372;
     
  8. Tsui JI, Rossi SL, Cheng DM, Bendiks S, Vetrova M, Blokhina E, Winter M, Gnatienko N, Backonja M, Bryant K, Krupitsky E, Samet JH. Pilot RCT comparing low-dose naltrexone, gabapentin and placebo to reduce pain among people with HIV with alcohol problems. PLoS One. 2024; 19(2):e0297948.View Related Profiles. PMID: 38408060; PMCID: PMC10896547; DOI: 10.1371/journal.pone.0297948;
     
  9. Stopka TJ, Babineau DC, Gibson EB, Knott CE, Cheng DM, Villani J, Wai JM, Blevins D, David JL, Goddard-Eckrich DA, Lofwall MR, Massatti R, DeFiore-Hyrmer J, Lyons MS, Fanucchi LC, Harris DR, Talbert J, Hammerslag L, Oller D, Balise RR, Feaster DJ, Soares W, Zarkin GA, Glasgow L, Oga E, McCarthy J, D'Costa L, Chahine R, Gomori S, Dalvi N, Shrestha S, Garner C, Shadwick A, Salsberry P, Konstan MW, Freisthler B, Winhusen J, El-Bassel N, Samet JH, Walsh SL. Impact of the Communities That HEAL Intervention on Buprenorphine-Waivered Practitioners and Buprenorphine Prescribing: A Prespecified Secondary Analysis of the HCS Randomized Clinical Trial. JAMA Netw Open. 2024 Feb 05; 7(2):e240132.View Related Profiles. PMID: 38386322; PMCID: PMC10884876; DOI: 10.1001/jamanetworkopen.2024.0132;
     
  10. Rosen S, Blokhina E, Truong V, Bereznicka A, Gnatienko N, Quinn E, Lioznov D, Krupitsky E, Michals A, Lunze K, Samet JH. Comparative costs and potential affordability of a multifaceted intervention to improve treatment outcomes among people with HIV who inject drugs in Russia: economic evaluation of the LINC-II randomized controlled trial. J Int AIDS Soc. 2024 Feb; 27(2):e26208.View Related Profiles. PMID: 38403887; PMCID: PMC10895073; DOI: 10.1002/jia2.26208;
     
Showing 10 of 469 results. Show More